Development of the Japanese version of the Challenging Experience Questionnaire
Neuropsychopharmacology Reports · 2024
DOI: 10.1002/npr2.12456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2024. Verfasst von Hideaki Tani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Hallucinogens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Introduction
The therapeutic potential of psychedelics for various mental disorders has gained significant interest. Previous studies have highlighted that psychedelics induce psychoactive effects, including challenging aspects of experiences. These experiences are assessed using the Challenging Experience Questionnaire (CEQ), yet its Japanese version has been unavailable. This study aimed to create a Japanese version of the CEQ.
Methods
We followed the “Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient‐Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation.” Initially, two Japanese psychiatrists independently conducted the forward translations. These were then reconciled into a single version, which was back‐translated into English. The original authors reviewed this back‐translation for accuracy, leading to revisions through continuous dialogue until the original authors approved the final version.
Results
The final, approved back‐translated version of the CEQ is presented in the figure.
Conclusions
This study developed a Japanese version of the CEQ, enabling the assessment of challenging experiences during psychedelic‐assisted therapy for Japanese speakers. Further studies are needed to assess the reliability and validity of this newly translated version.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
- Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Shinichiro Nakajima, Hiroyuki Uchida
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Tani, H., Yonezawa, K., Kusudo, K., Barrett, F. S., Nakajima, S., & Uchida, H. (2024). Development of the Japanese version of the Challenging Experience Questionnaire. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12456
Vancouver
Tani H, Yonezawa K, Kusudo K, Barrett FS, Nakajima S, Uchida H. Development of the Japanese version of the Challenging Experience Questionnaire. Neuropsychopharmacology Reports. 2024. doi:10.1002/npr2.12456
BibTeX
@article{Tani2024,
author = {Tani, Hideaki and Yonezawa, Kengo and Kusudo, Keisuke and Barrett, Frederick S and Nakajima, Shinichiro and Uchida, Hiroyuki},
title = {Development of the Japanese version of the Challenging Experience Questionnaire},
journal = {Neuropsychopharmacology Reports},
year = {2024},
doi = {10.1002/npr2.12456}
}
EUVIMED